Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid Carcinoma.
Limberg J, Egan CE, Gray KD, Singh M, Loewenstein Z, Yang Y, Riascos MC, Al Asadi H, Safe P, El Eshaky S, Liang H, Ullmann TM, Wang W, Li W, Zhang T, Xiang J, Stefanova D, Jin MM, Zarnegar R, Fahey TJ, Min IM.
Limberg J, et al. Among authors: jin mm.
Mol Cancer Res. 2023 May 1;21(5):397-410. doi: 10.1158/1541-7786.MCR-21-0832.
Mol Cancer Res. 2023.
PMID: 36790391
Free PMC article.